Literature DB >> 20961789

[Frequency of red blood cell alloimmunization in polytransfused patients at the university teaching hospital of Point G, Bamako, Mali].

M Baby1, S Fongoro, M Cissé, Y Gakou, M Bathily, A K Dembélé, M K Maïga, A Tounkara, D A Diallo.   

Abstract

This prospective study conducted within 9 months period aimed to determine the frequency of red cell alloimmunization among polytransfused patients of the medical Hematology and oncology ward, and the unit of hemodialysis of the Nephrology ward at the Point-G hospital. Irregular red blood cell antibody screening and identification were performed by gel-filtration method using indirect antiglobulin test and enzymatic treated cells. We did not use saline medium. A total of 78 patients were included in this study. The mean age of the patients was 36.78±14.73 years (range: 11 and 77 years). The sex ratio was of 1.11 in favour of the women. The mean blood units transfused were 12.21±9.99 units (range: 4 and 45 units). The Rhesus phenotypes Dccee, DccEe and DCcee were most predominant, with the respective frequencies of 67.9, 15.4 and 10.3%. Kell antigen was found at a frequency of 1.28%. The total rate of red cell alloimmunization was 10.3%. There was no significant difference between the two wards. All the screened agglutinins were warm antibodies belonging to the Rhesus system: anti-E (7.7%), anti-C (1.3%) and anti-D (1.3%). Only Anti-E was present among hematologic patients. We did not find a significant link between the sex, the age, the number of blood units transfused and the positivity of the antibody screening. We conclude that the frequency of post-transfusional alloimmunization is high among polytransfused patients in Mali. A systematic antibody screening among these patients and the selection of red cells with known Rhesus/Kell phenotypes would allow an optimal blood transfusion safety.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20961789     DOI: 10.1016/j.tracli.2010.06.026

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  6 in total

1.  Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.

Authors:  Gláucia A S Guelsin; Camila Rodrigues; Jeane E L Visentainer; Paula De Melo Campos; Fabíola Traina; Simone C O Gilli; Sara T O Saad; Lilian Castilho
Journal:  Blood Transfus       Date:  2014-06-12       Impact factor: 3.443

2.  Evaluation of the New Lateral Flow Card MDmulticard® Basic Extended Phenotype in Routine Clinical Practice.

Authors:  Beate Mayer; Julia Müller; María-José Candela-García; Annie-Claude Manteau; Christof Weinstock; Axel Pruß
Journal:  Transfus Med Hemother       Date:  2018-03-09       Impact factor: 3.747

3.  Blood transfusion, serum ferritin, and iron in hemodialysis patients in Africa.

Authors:  Leonard Kouegnigan Rerambiah; Laurence Essola Rerambiah; Armel Mbourou Etomba; Rose Marlène Mouguiama; Phanie Brunelle Issanga; Axel Sydney Biyoghe; Batchelili Batchilili; Sylvestre Akone Assembe; Joel Fleury Djoba Siawaya
Journal:  J Blood Transfus       Date:  2015-01-11

4.  Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, Kenya.

Authors:  Caroline Mangare; Amos Mbugua; Peter Maturi; Jamila Rajab; Rainer Blasczyk; Hans-Gert Heuft
Journal:  Afr J Lab Med       Date:  2015-09-25

5.  Red blood cell alloimmunisation in multi-transfused patients from an haemodialysis service in Burkina Faso.

Authors:  Koumpingnin Nebie; Salam Sawadogo; Salifo Sawadogo; Jérôme Koulidiati; Habi Y A Lengani; Abdoul G Sawadogo; Jérôme Babinet; Mohammed Khalloufi; Saliou Diop; Eléonore Kafando
Journal:  Afr J Lab Med       Date:  2022-09-26

6.  [Red blood cell alloimmunization among polytransfused patients in the National Hospital and University Center of Cotonou: about 51 cases].

Authors:  Tatiana Baglo; Alban Zohoun; Bruno Léopold Agboton; Jacques Vigan; Paolo Ayaka; Ludovic Anani; Awa Omar Touré Fall; Dorothée Kindé Gazard
Journal:  Pan Afr Med J       Date:  2021-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.